Pas de connexion internet — affichage de la version enregistrée de la page.

TG Therapeutics I…

USUSD
← Vers le Screener
US:TGTXMI:1TGTX

TG Therapeutics Inc (US:TGTX) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
tgtherapeutics.com
Secteur
Health Care · Biotechnology: Pharmaceutical Preparations
Siège Social
New York City, United States
PDG
Michael S. Weiss
Employés
399
Actions en Circulation
153.07 M au 2026-08-03
Flottant
135.24 M
Capitalisation Boursière
8.31 Md USD
Initiés
7.47%
Investisseurs Institutionnels
74.41%
Secteur d'Activité (SIC)
Pharmaceutical Preparations
ISIN
US88322Q1085
LEI
529900X21UKABN9NJ529
FCF
17.4 M USD
Dette
745 M USD
15 ans de FCF
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
Description

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina.

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksTGTX principaleUSD53.34 +0.74%actions ordinaires
MI Borsa Italiana (Milan)1TGTX secondaireEUR47.6 -2.26%actions ordinaires

Cours sur 3 Mois

jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas
publicité

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
Blackrock Inc.14.41%22.05 M2026-06-30
WEISS MICHAEL S (Chief E…≈6.39%9.78 M2026-01-08
iShares Trust-iShares Co…5.25%8.03 M2026-08-31
Vanguard Portfolio Manag…5.2%7.96 M2026-06-30
State Street Corporation5.09%7.79 M2026-06-30
Vanguard Capital Managem…4.02%6.15 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.86%4.38 M2026-06-30
iShares Trust-iShares Ru…2.42%3.71 M2026-08-31
Geode Capital Management…2.38%3.64 M2026-06-30
Shaw D.E. & Co., Inc.2.22%3.4 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.06%3.16 M2026-06-30
Soleus Capital Managemen…1.91%2.93 M2026-06-30
Price (T.Rowe) Associate…1.81%2.77 M2026-06-30
ClearBridge Investments,…1.73%2.65 M2026-06-30
Congress Asset Managemen…1.7%2.6 M2026-06-30
SPDR SERIES TRUST-State…1.47%2.25 M2026-08-31
VANGUARD INDEX FUNDS-Van…1.19%1.82 M2026-06-30
Fidelity Salem Street Tr…1.04%1.59 M2026-07-31
First TRT Exch-Trd Fd.-F…1.04%1.59 M2026-08-31
VANGUARD INDEX FUNDS-Van…0.99%1.51 M2026-06-30
iShares Trust-iShares Ru…0.89%1.36 M2026-08-31
POWER SEAN A (Chief Fina…≈0.52%798 1112026-01-08
HOBERMAN KENNETH (Direct…≈0.18%279 6532025-06-12
ECHELARD YANN (Director)≈0.15%223 8162025-11-24
HUME DANIEL (Director)≈0.13%192 7482025-06-12
CHARNEY LAURENCE NEIL (D…≈0.11%168 6402026-09-10
LONIAL SAGAR (Director)≈0.06%94 0612025-09-11